These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 10187895)
41. Effects of tenidap on leukocyte-endothelial cell adhesion in mesenteric venules. Panés J; Russell JM; Wolf RE; Wallace JL; Granger DN J Rheumatol; 1995 Mar; 22(3):444-9. PubMed ID: 7783059 [TBL] [Abstract][Full Text] [Related]
42. In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock. Childs EW; Udobi KF; Wood JG; Hunter FA; Smalley DM; Cheung LY Shock; 2002 Nov; 18(5):423-7. PubMed ID: 12412620 [TBL] [Abstract][Full Text] [Related]
43. Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock. Schurr MJ; Fabian TC; Croce MA; Geraci SA; Proctor KG Surgery; 1997 May; 121(5):493-500. PubMed ID: 9142146 [TBL] [Abstract][Full Text] [Related]
44. Effects of platelet-activating factor on arteriolar and venular tone in rat trachea. Collins LC; Roberts AM Microvasc Res; 1997 Jan; 53(1):63-72. PubMed ID: 9056476 [TBL] [Abstract][Full Text] [Related]
45. Influence of the bradykinin B1/B2-receptor-antagonist B 9430 on the cerebral microcirculation and outcome of gerbils from global cerebral ischemia. Lehmberg J; Beck J; Baethmann A; Uhl E Acta Neurochir Suppl; 2000; 76():39-41. PubMed ID: 11450051 [TBL] [Abstract][Full Text] [Related]
47. Effects of moderate hypothermia on leukocyte- endothelium interaction in the rat pial microvasculature after transient middle cerebral artery occlusion. Ishikawa M; Sekizuka E; Sato S; Yamaguchi N; Inamasu J; Bertalanffy H; Kawase T; Iadecola C Stroke; 1999 Aug; 30(8):1679-86. PubMed ID: 10436121 [TBL] [Abstract][Full Text] [Related]
48. Downstream Microvascular Thrombosis in Cortical Venules Is an Early Response to Proximal Cerebral Arterial Occlusion. Desilles JP; Syvannarath V; Di Meglio L; Ducroux C; Boisseau W; Louedec L; Jandrot-Perrus M; Michel JB; Mazighi M; Ho-Tin-Noé B J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29496683 [TBL] [Abstract][Full Text] [Related]
49. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro. Hirafuji M; Shinoda H Br J Pharmacol; 1991 Jun; 103(2):1333-8. PubMed ID: 1884095 [TBL] [Abstract][Full Text] [Related]
50. Pial microvascular responses to transient bilateral common carotid artery occlusion: effects of hypertonic glycerol. Lapi D; Marchiafava PL; Colantuoni A J Vasc Res; 2008; 45(2):89-102. PubMed ID: 17934320 [TBL] [Abstract][Full Text] [Related]
51. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart. Hu W; McNicholl IK; Choy PC; Man RY Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237 [TBL] [Abstract][Full Text] [Related]
52. Leukocyte-platelet aggregate adhesion and vascular permeability in intact microvessels: role of activated endothelial cells. He P; Zhang H; Zhu L; Jiang Y; Zhou X Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H591-9. PubMed ID: 16517944 [TBL] [Abstract][Full Text] [Related]
54. Platelet-activating factor-induced microvascular dysfunction: role of adherent leukocytes. Kubes P; Suzuki M; Granger DN Am J Physiol; 1990 Jan; 258(1 Pt 1):G158-63. PubMed ID: 2301577 [TBL] [Abstract][Full Text] [Related]
55. Resistance and exchange microvessels are modulated by different PAF receptors. Tomeo AC; Durán WN Am J Physiol; 1991 Nov; 261(5 Pt 2):H1648-52. PubMed ID: 1659229 [TBL] [Abstract][Full Text] [Related]
56. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium. Casale TB; Erger RA; Little MM Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250 [TBL] [Abstract][Full Text] [Related]
57. Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. Zimmerman BJ; Holt JW; Paulson JC; Anderson DC; Miyasaka M; Tamatani T; Todd RF; Rusche JR; Granger DN Am J Physiol; 1994 Mar; 266(3 Pt 2):H847-53. PubMed ID: 8160832 [TBL] [Abstract][Full Text] [Related]
58. Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock. Giral M; Balsa D; Ferrando R; Merlos M; Garcia-Rafanell J; Forn J Br J Pharmacol; 1996 Jul; 118(5):1223-31. PubMed ID: 8818347 [TBL] [Abstract][Full Text] [Related]
59. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity. Grigoriadis G; Stewart AG Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761 [TBL] [Abstract][Full Text] [Related]
60. Modulation of microvascular hydraulic permeability by platelet-activating factor. Victorino GP; Newton CR; Curran B J Trauma; 2004 Feb; 56(2):379-84. PubMed ID: 14960983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]